Weibo is rated HOLD due to limited growth visibility and ongoing uncertainties in its core advertising business. WB's operating metrics, including MAU and DAU, continue to decline, raising questions about long-term relevance amid intensifying competition. Despite stagnating user growth, WB's engagement and video initiatives show early promise, supported by strong supply-side stability.

Markets are clawing back from a brutal Thursday selloff, but the real action is in the analyst calls, where BMO Capital just pulled the trigger on three major chip stocks at once and DZ Bank opened SpaceX coverage with a Sell.

I present the July 2026 ReFa/Ro Dogs list, highlighting high-yield dividend stocks selected by reader engagement and quantitative metrics. Top ten ReFa/Ro Dogs offer projected net gains of 25.61% to 72.48% by July 2027, with all passing the IDEAL test—dividends from $1k invested exceed the share price. Analyst targets suggest an average 43.8% net gain for the top ten, with the five lowest-priced yielding dogs forecast to outperform the group by 5.77%.

Weibo Corporation (WB) Q2 2026 Earnings Call Transcript

Weibo NASDAQ: WB reported second-quarter 2026 revenue growth of 2% as gains in value-added services offset a modest decline in advertising revenue amid cautious spending by advertisers in several industries.

HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (Nasdaq: WB and HKEX: 9898), a leading social media in China, today announced its unaudited financial results for the second quarter ended June 30, 2026. "We delivered a solid quarter," said Gaofei Wang, CEO of Weibo.

/PRNewswire/ -- Weibo Corporation (NASDAQ: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its

July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Inversiones, Weibo, Verizon, and AT&T, as ideal buys. Analyst targets project average net gains of 40.39% for the top ten GVAS stocks by July 2027, with risk profiles generally below market volatility. The dividend dogcatcher strategy favors stocks whose $1K dividend income exceeds share price, with 36 of 54 GVAS stocks meeting this ideal condition.

Dividend stocks are regaining appeal as interest rates fall and market volatility rises, offering higher returns and lower risk over time. Top ten Attractive Low Price Dogs are forecasted to deliver 29.51%–66.09% net gains by June 2027, with average risk 49% below the market. All top ten yield Attractive Low Price Dogs are fairly priced, with dividends from $1K invested exceeding or matching share prices.

HAYWARD, Calif.--(BUSINESS WIRE)--Applied Biomics launches Antigen Affinity Purified HCP Antibody delivering 95% HCP coverage for ELISA, WB and LC-MS workflows.